Australasian Ocular Melanoma Alliance
The Australasian Ocular Melanoma Alliance (AOMA) is the peak national body representing medical, para-medical, nursing and consumer representatives who aim to improve the care and treatment of ocular melanoma patients in Australia and around the world. The alliance also provides online information and support services for people affected by ocular melanoma. AOMA members include ophthalmologists, surgeons, medical and radiation oncologists, pathologists, allied health specialists, scientists, researchers and consumer representatives from across Australia and New Zealand. The focus of this extensive collaboration is treatment paradigms for ocular melanoma, and current and future research. AOMA was founded in 2017 by Melanoma and Skin Cancer Trials (MASC Trials) and is a MASC Trials priority research special interest group.